GlobalData on MSN15h
Vaxxas completes enrolment in Phase I H7N9 bird flu vaccine trial
The patch-delivered vaccine trial received $28.5m in funding from US authorities as a potential pandemic preparation.
Daily1h
FDA Approves Vimkunya for prevention of Chikungunya
The US Food and Drug Administration (FDA) has granted accelerated approval to Vimkunya™, a recombinant chikungunya vaccine, ...
Vaxxas Completes Enrollment for Largest Clinical Trial of High-Density Microarray Patch (HD-MAP) For Vaccine Delivery
Vaxxas, a clinical-stage biotechnology company, today announced it has completed enrollment for its Phase I clinical trial of a vaccine against an avian influenza A (H7N9) virus with pandemic ...
Cure Today2d
Cancer Vaccine Elicits Promising Responses in Renal Cell Carcinoma
All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.
EQS-News: Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
EQS-News: GeoVax, Inc. / Key word (s): Financial Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification 19.02.2025 / 15:04 CET/CEST The issuer is solely responsible for the ...
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...